ES2656474T3 - Osteopontina láctea de origen mamífero para potenciar la capacidad de respuesta inmune - Google Patents

Osteopontina láctea de origen mamífero para potenciar la capacidad de respuesta inmune Download PDF

Info

Publication number
ES2656474T3
ES2656474T3 ES14735964.0T ES14735964T ES2656474T3 ES 2656474 T3 ES2656474 T3 ES 2656474T3 ES 14735964 T ES14735964 T ES 14735964T ES 2656474 T3 ES2656474 T3 ES 2656474T3
Authority
ES
Spain
Prior art keywords
osteopontin
immune response
mammalian origin
enhance immune
response capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14735964.0T
Other languages
English (en)
Inventor
Anne Staudt Kvistgaard
Peter Langborg WEJSE
Sharon DONOVAN
Marcia H. Monaco SIEGEL
Sarah S. Comstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Foods AMBA
Original Assignee
Arla Foods AMBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods AMBA filed Critical Arla Foods AMBA
Application granted granted Critical
Publication of ES2656474T3 publication Critical patent/ES2656474T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Osteopontina láctea de origen mamífero para uso como medicamento para potenciar la resistencia inmune a una enfermedad infecciosa en un mamífero, en donde la osteopontina es para administración oral.
ES14735964.0T 2013-07-05 2014-07-04 Osteopontina láctea de origen mamífero para potenciar la capacidad de respuesta inmune Active ES2656474T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361843185P 2013-07-05 2013-07-05
US201361843185P 2013-07-05
EP13175267 2013-07-05
EP13175267 2013-07-05
PCT/EP2014/064339 WO2015001092A1 (en) 2013-07-05 2014-07-04 Mammalian milk osteopontin for enhancing immune responsiveness

Publications (1)

Publication Number Publication Date
ES2656474T3 true ES2656474T3 (es) 2018-02-27

Family

ID=48740972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14735964.0T Active ES2656474T3 (es) 2013-07-05 2014-07-04 Osteopontina láctea de origen mamífero para potenciar la capacidad de respuesta inmune

Country Status (18)

Country Link
US (2) US9956283B2 (es)
EP (1) EP3016673B1 (es)
JP (1) JP6509833B2 (es)
KR (1) KR102307002B1 (es)
CN (1) CN105407910B (es)
AU (1) AU2014286123B2 (es)
BR (1) BR112016000067B1 (es)
CA (1) CA2916821C (es)
CL (1) CL2015003803A1 (es)
DK (1) DK3016673T3 (es)
EA (1) EA034654B1 (es)
ES (1) ES2656474T3 (es)
MX (1) MX369925B (es)
NZ (1) NZ715430A (es)
PH (1) PH12015502844A1 (es)
PL (1) PL3016673T3 (es)
PT (1) PT3016673T (es)
WO (1) WO2015001092A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3095082A1 (en) * 2018-04-25 2019-10-31 Health And Happiness (H&H) Hong Kong Limited Combinations of osteopontin and 2'-fucosyllactose for use as medicaments
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum
CN113424962A (zh) * 2020-09-21 2021-09-24 黑龙江飞鹤乳业有限公司 提高免疫力的营养组分、含有其的食品或保健品及其用途
CN113475720B (zh) * 2021-06-15 2023-07-25 合生元（广州）健康产品有限公司 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用
WO2023144416A1 (en) 2022-01-31 2023-08-03 Société des Produits Nestlé S.A. Compositions comprising osteopontin (opn)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056405A1 (en) 1997-06-10 1998-12-17 Whitehead Institute For Biomedical Research A method of modulating immune response with osteopontin
AU749530B2 (en) * 1997-06-11 2002-06-27 Acorda Therapeutics, Inc. CNS neuroregenerative compositions and methods of use
CA2370129A1 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Methods and compositions for modulating an immune response
AU784322B2 (en) 2000-01-07 2006-03-09 Arla Foods Amba A process for isolation of osteopontin from milk
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
US7205398B2 (en) * 2002-05-24 2007-04-17 Schering-Plough Animal Health Corporation Eta-1 gene and methods for use
US20050287247A1 (en) * 2003-09-18 2005-12-29 Sorensen Esben S Infant formula
WO2005025333A1 (en) 2003-09-18 2005-03-24 Arla Foods Amba Infant formula
KR20090123115A (ko) * 2008-05-27 2009-12-02 한국생명공학연구원 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법
CA2828746C (en) * 2011-03-03 2019-05-07 Arla Foods Amba Method for isolating osteopontin using concentrated feeds
BR112014013565A2 (pt) 2011-12-07 2019-09-24 Arla Foods Amba variante da opn para uso no tratamento ou prevenção de câncer envolvendo pelo menos um tumor canceroso, método de tratamento ou prevenção do câncer, composição farmacêutica e suplemento nutricional

Also Published As

Publication number Publication date
CL2015003803A1 (es) 2016-08-05
KR20160030960A (ko) 2016-03-21
AU2014286123B2 (en) 2019-02-28
KR102307002B1 (ko) 2021-10-05
NZ715430A (en) 2022-01-28
PH12015502844B1 (en) 2016-03-28
BR112016000067A2 (es) 2017-09-05
MX369925B (es) 2019-11-25
US10772955B2 (en) 2020-09-15
CA2916821C (en) 2023-10-03
EA201690057A1 (ru) 2016-07-29
US20180289798A1 (en) 2018-10-11
PH12015502844A1 (en) 2016-03-28
CN105407910B (zh) 2019-12-03
PL3016673T3 (pl) 2018-04-30
US9956283B2 (en) 2018-05-01
PT3016673T (pt) 2018-01-30
EP3016673B1 (en) 2017-10-25
US20160136268A1 (en) 2016-05-19
CN105407910A (zh) 2016-03-16
EA034654B1 (ru) 2020-03-03
DK3016673T3 (da) 2018-01-29
MX2016000107A (es) 2016-06-07
CA2916821A1 (en) 2015-01-08
EP3016673A1 (en) 2016-05-11
JP2016529217A (ja) 2016-09-23
AU2014286123A1 (en) 2016-01-21
WO2015001092A1 (en) 2015-01-08
BR112016000067B1 (pt) 2022-08-30
JP6509833B2 (ja) 2019-05-08

Similar Documents

Publication Publication Date Title
TWD162495S (zh) 垃圾筒
UY34782A (es) Anticuerpos humanos para fel d1 y métodos para usarlos.
PE20150196A1 (es) Jeringa
TWD167893S (zh) 戒指
TWD166000S (zh) 銷售點基座（一）
TWD158887S (zh) 粉餅盒
ES2656474T3 (es) Osteopontina láctea de origen mamífero para potenciar la capacidad de respuesta inmune
TWD171288S (zh) 真空清潔器
EA201500043A1 (ru) Лекарственная форма для продленного высвобождения действующих веществ
TWD174988S (zh) 椅子
TWD163797S (zh) 液體收集器
TWD163566S (zh) 心電圖監視器
TWD160303S (zh) 真空吸塵器
TWD157486S (zh) 椅子（四）
TWD165862S (zh) 椅子
TWD167388S (zh) 牙刷
TWD161936S (zh) 血糖機
TWD163288S (zh) 垃圾桶
TWD157963S (zh) 餐具(一)
TWD166057S (zh) 提包
TH1501000071A (th) องค์ประกอบทางเภสัชกรรมที่มีการพัฒนาความสามารถในการไหล ตัวช่วยทางการแพทย์ และวิธีการผลิต และวิธีการใช้
TWD162681S (zh) 擠壓瓶(一)
TWD166775S (zh) 提包
TWD165813S (zh) 照護用厠所
TWD167389S (zh) 牙刷